The estimated Net Worth of Pat Beyer is at least $4.32 Milione dollars as of 30 April 2024. Mr Beyer owns over 3,000 units of Conmed stock worth over $792,910 and over the last 10 years he sold CNMD stock worth over $2,594,718. In addition, he makes $932,455 as Pres of International & Global Orthopedics at Conmed.
Mr has made over 10 trades of the Conmed stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 3,000 units of CNMD stock worth $204,900 on 30 April 2024.
The largest trade he's ever made was exercising 106,000 units of Conmed stock on 29 October 2021 worth over $4,806,040. On average, Mr trades about 7,654 units every 182 days since 2015. As of 30 April 2024 he still owns at least 10,807 units of Conmed stock.
You can see the complete history of Mr Beyer stock trades at the bottom of the page.
Patrick J. Beyer is the Pres of International & Global Orthopedics at Conmed.
As the Pres of International & Global Orthopedics of Conmed, the total compensation of Mr Beyer at Conmed is $932,455. There are 1 executives at Conmed getting paid more, with Curt R. Hartman having the highest compensation of $1,787,620.
Mr Beyer is 55, he's been the Pres of International & Global Orthopedics of Conmed since . There are 4 older and 5 younger executives at Conmed. The oldest executive at Conmed Corp. is David R. Murray, 73, who is the Pres of ConMed Electrosurgery.
Pat's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.
Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti e Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
Conmed executives and other stock owners filed with the SEC include: